LCD L38292: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease — Palmetto GBA
Policy LCD-L38292 · Oncology
New genomic assay coverage requires billing team review.
Code intelligence
Z85.46 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code Z85.46.
Normal code riskView ICD-10 detail
Signal breakdown
3 shown · 3 total in platform
Risk: Normal
0
Critical
0%
0
High
0%
3
Routine
100%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Routine
LCD L38339: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease — Noridian
Policy LCD-L38339 · Oncology
New assay coverage may influence prostate cancer billing practices.
LCD L39686: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers — Noridian
Policy LCD-L39686 · Oncology
Key updates for prostate cancer decision-making tests.
Audit documentation
Building an audit file that includes Z85.46?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription